Photodermatology Photoimmunology & Photomedicine

Papers
(The H4-Index of Photodermatology Photoimmunology & Photomedicine is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Analysis of related factors affecting hemoporfin‐mediated photodynamic therapy for port‐wine stain: A retrospective study51
Carcinogenic risk in patients treated with UVA‐1 phototherapy: A 5‐year retrospective study47
Photoprotective Effect of Taurine‐Rich Protamex Extract From Salmon (Oncorhynchus keta) Byproduct Against Ultraviolet B‐Induced Skin Damage in Human Dermal Fibroblasts and Zebrafish 31
Could OTC Devices Reduce Disparity of Care? A Comparison of the Spectral Output of Home‐Based Narrow‐Band UVB Phototherapy Devices to a Prescription Device27
Gain of Protection Afforded by the Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (MCE) UVA1 Filter on Pigmentary and Aging Signs: An Outdoor 4‐Week Randomized, Int24
An unusual case of solar urticaria exacerbated by clothing: Confirmation through phototesting22
ALA‐PDT and pulsed dye laser combined with oral antiandrogen drug in the treatment of cystic acne in a patient with hyperandrogenism21
21
Generalized lichen sclerosus responding to UVA1 phototherapy and methotrexate treatment: A case report16
Visual Aids for Sunscreen Application: A mixed methods study14
Topical calcipotriol in comparison with narrow band UVB phototherapy on tissue levels of active vitamin D (1,25 di‐hydroxycholecalciferol) in psoriatic plaques13
UVA1 phototherapy as a novel adjunct treatment for acute inflammations and neuralgia of herpes zoster13
Clinical and molecular change induced by repeated low‐dose visible light exposure in both light‐skinned and dark‐skinned individuals12
Efficacy and tolerance of Oral minocycline combined with photobiomodulation therapy for rosacea: An evaluator‐blinded randomized, controlled clinical trial12
Issue Information12
0.13765001296997